Sweden· SE-20060828000020
ADENURIC 120 mg Filmdragerad tablett
A medicinal product containing febuxostat, registered in Sweden by Menarini International Operations Luxembourg SA.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Febuxostat
- Manufacturer
- Menarini International Operations Luxembourg SA
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20060828000020
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Febuxostat in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaADENURICMenarini International Operations Luxembourg S.A., Luxembourg
- SpainADENURIC 120 MG COMPRIMIDOS RECUBIERTOS CON PELICULAMenarini International Operations Luxembourg S.A.
- ItalyADENURICMENARINI INTERNAT. O.L.S.A
- PolandAdenuricMenarini International Operations Luxembourg S.A.
- NetherlandsAdenuric 120 mg, filmomhulde tablettenMenarini International Operations Luxembourg S.A.
- IrelandAdenuric120 mg film-coated tabletsMenarini International Operations Luxembourg S.A.
- FranceADENURIC 120 mg, comprimé pelliculéMENARINI INTERNATIONAL OPERATIONS LUXEMBOURG
- FinlandADENURICMenarini International Operations Luxembourg S.A.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Feburo, Febuxostat +pharma
- Belgium · Feburik, Febuxostat Ab
- Bulgaria · Адара, Адара 80 Mg Филмирани Таблетки
- Cyprus · Febuxostat Genepharm, Urichofeb
- Czechia · Febuxostat Sandoz
- Germany · Febuxodor, Febuxostat 1 A Pharma
- Denmark · Febuxostat Accord, Febuxostat Teva
- Estonia · Druniler, Febuxostat Alembic
- Spain · Febuxostat Aurovitas, Febuxostat Cinfa
- Finland · Febuxostat Accord
- France · Febuxostat Accord, Febuxostat Almus
- United Kingdom (Northern Ireland) · Elstabya, Febuxostat
- Greece · Buxodem, Febuxostat Genepharm
- Croatia · Abuxar, Febuksostat
- Hungary · Denofix, Doluric
- Ireland · Febuxostat Clonmel, Febuxostat Rowa
- Iceland · Adenuric, Febuxostat Krka
- Italy · Alphabux, Arbux
- Liechtenstein · Adenuric, Febuxostat Viatris
- Lithuania · Druniler, Febuxostat Teva
- Luxembourg · Feburik, Febuxostat
- Latvia · Denofix, Druniler
- Malta · Febuxostat Pharos
- Netherlands · Feburik, Febuxostat Laboratorios Liconsa
- Norway · Adenuric, Febuxostat Krka
- Poland · Denofix, Febuxostat Aurovitas
- Portugal · Bluesar, Febuxostate Aristo
- Slovenia · Abuxar
- Slovakia · Febuxostat Sandoz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5a796828-6000-478f-a447-67d85d139483 GET /v1/drugs/5a796828-6000-478f-a447-67d85d139483?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EPAR",
"EMA"
],
"se_npl_id": "20060828000020",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20060828000020",
"product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/adenuric-epar-product-information_sv.pdf"
}See everything about febuxostat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.